Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Twist Bioscience Corporation TWST

Healthcare  —  Diagnostics & Research
182.83 (1.20) (0.65%) as of 25 Sep
Market cap
$12.4B
P/E
0.0×
Revenue Champion (5y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Twist Bioscience Corporation (TWST) Business Profile

Updated before January 2025

Company Overview

Twist Bioscience Corporation (NASDAQ: TWST) is a biotechnology company that specializes in synthetic DNA production and genomic solutions. Founded in 2013 by Emily Leproust, Bill Peck, and Bill Banyai, the company is headquartered in South San Francisco, California. Twist Bioscience leverages its proprietary silicon-based DNA synthesis platform to produce high-quality synthetic DNA at scale. The company’s innovative approach has positioned it as a leader in the synthetic biology and genomics industries.

Twist Bioscience’s leadership team is spearheaded by Dr. Emily Leproust, who serves as the CEO and President. Dr. Leproust is a recognized pioneer in synthetic biology and has been instrumental in driving the company’s growth and innovation. Other key executives include Jim Thorburn, the Chief Financial Officer, and Patrick Weiss, the Chief Operating Officer. Together, the leadership team has guided Twist Bioscience to become a prominent player in the biotechnology sector.

Core Business Segments

Twist Bioscience operates across several core business segments, offering a diverse range of products and services that cater to various industries, including healthcare, agriculture, and industrial biotechnology. The major product categories include:

1. Synthetic DNA Products

Twist Bioscience’s flagship offering is its synthetic DNA, which is produced using its proprietary silicon-based DNA synthesis platform. This platform allows the company to manufacture DNA with high precision, speed, and cost efficiency. Key products in this category include:

  • Genes and Gene Fragments: Custom-designed DNA sequences for research and development purposes.
  • Oligonucleotide Pools: High-quality DNA oligos for applications such as CRISPR gene editing and drug discovery.
  • NGS (Next-Generation Sequencing) Tools: DNA libraries and enrichment tools for genomic research.

2. Biopharma Solutions

Twist Bioscience provides solutions for the biopharmaceutical industry, including antibody discovery and optimization services. These services are designed to accelerate drug development and improve therapeutic outcomes. Key offerings include:

  • Twist Biopharma: A platform for antibody discovery and optimization using synthetic DNA.
  • Custom Libraries: Tailored DNA libraries for drug discovery and development.

3. Data Storage Solutions

One of Twist Bioscience’s most innovative ventures is its DNA-based data storage technology. This cutting-edge solution leverages synthetic DNA as a medium for storing digital information, offering a sustainable and scalable alternative to traditional data storage methods.

4. Industrial and Agricultural Applications

Twist Bioscience also serves the industrial and agricultural sectors by providing synthetic DNA for applications such as crop improvement, biofuel production, and industrial enzyme development.

Business Model

Twist Bioscience’s business model is built on the integration of its proprietary technology, diverse product portfolio, and strategic partnerships. The company generates revenue through the sale of synthetic DNA products, biopharma solutions, and data storage services. Additionally, Twist Bioscience collaborates with academic institutions, research organizations, and commercial enterprises to drive innovation and expand its market reach.

The company’s silicon-based DNA synthesis platform is a key differentiator, enabling it to produce high-quality DNA at scale and lower costs compared to traditional methods. This technological advantage has allowed Twist Bioscience to establish a strong foothold in the synthetic biology market.

Strategic Direction

Twist Bioscience is focused on driving growth through innovation, sustainability, and market expansion. Key strategic initiatives include:

  • Expansion of Product Offerings: The company aims to develop new products and services to address emerging needs in synthetic biology, genomics, and data storage.
  • Sustainability Goals: Twist Bioscience is committed to reducing its environmental footprint by adopting sustainable manufacturing practices and promoting the use of synthetic DNA in eco-friendly applications.
  • Global Market Penetration: The company plans to expand its presence in international markets, particularly in regions with growing demand for synthetic biology solutions.
  • Investment in R&D: Twist Bioscience continues to invest heavily in research and development to maintain its competitive edge and drive innovation.

Competitive Landscape

Twist Bioscience operates in a highly competitive market, facing competition from both established players and emerging startups. Key competitors include:

  • Integrated DNA Technologies (IDT): A leading provider of custom DNA and RNA synthesis services.
  • Thermo Fisher Scientific: A global biotechnology company offering a wide range of genomic solutions.
  • Ginkgo Bioworks: A synthetic biology company specializing in organism engineering.
  • Agilent Technologies: A provider of genomic and synthetic biology tools.

Despite the competitive landscape, Twist Bioscience’s proprietary technology and diverse product portfolio give it a significant advantage.

Risk Factors

Twist Bioscience faces several risks that could impact its business operations and financial performance. Key risk factors include:

  • Market Dependence: The company’s revenue is heavily reliant on the demand for synthetic DNA and related products.
  • Supply Chain Disruptions: Any disruptions in the supply chain could affect the company’s ability to meet customer demands.
  • Regulatory Challenges: The biotechnology industry is subject to stringent regulations, which could pose compliance challenges.
  • Competition: Intense competition from established players and new entrants could impact market share and profitability.
  • Economic Uncertainty: Global economic conditions, including inflation and currency fluctuations, could affect the company’s financial performance.

Recent Developments

Twist Bioscience has made significant strides in recent years, including:

  • Launch of New Products: The company has introduced several new products, including advanced NGS tools and custom DNA libraries.
  • Partnerships and Collaborations: Twist Bioscience has entered into strategic partnerships with leading research institutions and biotech companies to drive innovation.
  • Expansion of Manufacturing Capacity: The company has invested in expanding its manufacturing facilities to meet growing demand.
  • Advancements in DNA Data Storage: Twist Bioscience continues to make progress in developing its DNA-based data storage technology, positioning itself as a leader in this emerging field.

Investment Considerations

Investors considering Twist Bioscience should weigh the following strengths and risks:

Strengths

  • Proprietary silicon-based DNA synthesis platform.
  • Diverse product portfolio catering to multiple industries.
  • Strong focus on innovation and R&D.
  • Growing demand for synthetic biology solutions.

Risks

  • Dependence on a few key markets for revenue.
  • Exposure to regulatory and compliance risks.
  • Intense competition in the biotechnology sector.
  • Potential supply chain disruptions.

Conclusion

Twist Bioscience Corporation is a pioneering company in the synthetic biology and genomics industries. With its innovative technology, diverse product offerings, and strategic focus on growth and sustainability, Twist Bioscience is well-positioned to capitalize on the growing demand for synthetic DNA and related solutions. While the company faces certain risks, its strong market position and commitment to innovation make it a compelling choice for investors seeking exposure to the biotechnology sector.